Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Rasche

Showing results (71-80 of 170) with videos related to

Pageof 17
Sort By:
Blood Advances|July 1, 2025
Prognostic impact of focal lesion location and persistence in multiple myeloma: insights from serial PET/DWI imagingCarolina Schinke, Leo Rasche, Cody Ashby, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2021
<sup>68</sup>Ga-Pentixafor PET/CT for Detection of Chemokine Receptor CXCR4 Expression in Myeloproliferative NeoplasmsSabrina Kraus, Alexander Dierks, Leo Rasche, et al.
Cancers|April 29, 2020
<sup>18</sup>F-FDG and <sup>11</sup>C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET BiomarkersMaria I Morales-Lozano, Oliver Viering, Samuel Samnick, et al.
Blood Advances|January 29, 2026
Significant burden of low-grade infections in patients treated with T-cell-engaging therapies for Multiple MyelomaJulia Mersi, Lara Burow, Xiang Zhou, et al.
Future Oncology (London, England)|June 16, 2026
A plain language summary describing how talquetamab affects the way people with multiple myeloma feel and function in the MonumenTAL-1 studyCarolina Schinke, Cyrille Touzeau, Albert Oriol, et al.
Haematologica|October 5, 2023
Venetoclax salvage therapy in relapsed/refractory multiple myelomaMaximilian J Steinhardt, Marietta Truger, Max Bittrich, et al.
JACC. Advances|June 28, 2024
Allogeneic Hematopoietic Cell Transplantation Induces Vessel Wall Inflammation in Large ArteriesSebastian E Serfling, Wolfgang Thaiss, Anne Wasserloos, et al.
Cancers|August 23, 2020
18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical FeaturesXiang Zhou, Alexander Dierks, Olivia Kertels, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2016
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic FeaturesLeo Rasche, Christoph Röllig, Gernot Stuhler, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 17, 2026
Supportive care for talquetamab-related dysgeusia in multiple myeloma: mixed-methods evidence, nutrition-focused flowchart, and digital companion conceptAnna Fleischer, Magdalena Roll, Franziska Panther, et al.
Pageof 17

Showing results (71-80 of 170) with videos related to

Sort By:
Pageof 17
Blood Advances|July 1, 2025
Prognostic impact of focal lesion location and persistence in multiple myeloma: insights from serial PET/DWI imagingCarolina Schinke, Leo Rasche, Cody Ashby, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2021
<sup>68</sup>Ga-Pentixafor PET/CT for Detection of Chemokine Receptor CXCR4 Expression in Myeloproliferative NeoplasmsSabrina Kraus, Alexander Dierks, Leo Rasche, et al.
Cancers|April 29, 2020
<sup>18</sup>F-FDG and <sup>11</sup>C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET BiomarkersMaria I Morales-Lozano, Oliver Viering, Samuel Samnick, et al.
Blood Advances|January 29, 2026
Significant burden of low-grade infections in patients treated with T-cell-engaging therapies for Multiple MyelomaJulia Mersi, Lara Burow, Xiang Zhou, et al.
Future Oncology (London, England)|June 16, 2026
A plain language summary describing how talquetamab affects the way people with multiple myeloma feel and function in the MonumenTAL-1 studyCarolina Schinke, Cyrille Touzeau, Albert Oriol, et al.
Haematologica|October 5, 2023
Venetoclax salvage therapy in relapsed/refractory multiple myelomaMaximilian J Steinhardt, Marietta Truger, Max Bittrich, et al.
JACC. Advances|June 28, 2024
Allogeneic Hematopoietic Cell Transplantation Induces Vessel Wall Inflammation in Large ArteriesSebastian E Serfling, Wolfgang Thaiss, Anne Wasserloos, et al.
Cancers|August 23, 2020
18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical FeaturesXiang Zhou, Alexander Dierks, Olivia Kertels, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2016
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic FeaturesLeo Rasche, Christoph Röllig, Gernot Stuhler, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 17, 2026
Supportive care for talquetamab-related dysgeusia in multiple myeloma: mixed-methods evidence, nutrition-focused flowchart, and digital companion conceptAnna Fleischer, Magdalena Roll, Franziska Panther, et al.
Pageof 17